Jianjiang Xie Selected Research

Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)

7/2019

Identification of a novel lncRNA GABPB1-IT1 that is downregulated and predicts a poor prognosis in non-small cell lung cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jianjiang Xie Research Topics

Disease

7	Neoplasms (Cancer) 05/2023 - 01/2020
3	Lung Neoplasms (Lung Cancer) 01/2024 - 01/2023
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2024 - 05/2023
2	Adenocarcinoma of Lung 01/2023 - 01/2023
1	Neoplasm Metastasis (Metastasis) 03/2023
1	Prostatic Neoplasms (Prostate Cancer) 01/2023
1	Type 2 Diabetes Mellitus (MODY) 01/2020
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 07/2019

Drug/Important Bio-Agent (IBA)

3	Long Noncoding RNAIBA 05/2023 - 07/2019
2	Messenger RNA (mRNA)IBA 05/2023 - 01/2020
2	RNA (Ribonucleic Acid)IBA 05/2023 - 01/2023
2	Metformin (Glucophage)FDA LinkGeneric 01/2023 - 01/2020
1	vasectrin I (VS I)IBA 03/2023
1	vasectrin IIIIBA 03/2023
1	Circulating Tumor DNAIBA 03/2023
1	MucinsIBA 01/2023
1	IntegrinsIBA 01/2023
1	AntigensIBA 01/2023
1	Circular RNAIBA 01/2023
1	naphthol AS-E phosphateIBA 01/2021
1	Fructose-Bisphosphate Aldolase (Aldolase)IBA 01/2021
1	Glycerolphosphate Dehydrogenase (Glycerol 3 Phosphate Dehydrogenase)IBA 01/2020

Therapy/Procedure

4	Therapeutics 01/2024 - 01/2020